chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness on her left foot; Felt electric down her left leg; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on her left foot) and PAIN IN EXTREMITY (Felt electric down her left leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness on her left foot) and PAIN IN EXTREMITY (Felt electric down her left leg). At the time of the report, HYPOAESTHESIA (Numbness on her left foot) had not resolved and PAIN IN EXTREMITY (Felt electric down her left leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Local redness & swelling - started - by 4-5 pm on 1-5-09 - gotten progressively worse & longer. > 50 cent. noted at office visit 1-7-09 445pm.
Pain at injection site. It has progressed to severe shoulder and arm pain starting 03/08/2021 that is still increasing
THREW UP TWICE; BODY ACHES; JOINT PAIN; FELT WEAK; 103 DEGREE FEVER; CHILLS DESCRIBED AS SHE WAS JUMPING THE CHILLS WERE SO STRONG, AND THEY WERE BETTER DURING THE DAYTIME,; This spontaneous report received from a parent concerned a 31 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included social alcohol user, non smoker, and birth control pills, and other pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On 09-MAR-2021, the subject experienced chills which were described as she was jumping the chills were so strong, and they were better during the daytime. On 09-MAR-2021 11:00, the subject experienced 103 degree fever. On 10-MAR-2021, the subject experienced threw up twice. On 10-MAR-2021, the subject experienced body aches. On 10-MAR-2021, the subject experienced joint pain. On 10-MAR-2021, the subject experienced felt weak. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 C. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from 103 degree fever, and threw up twice on 10-MAR-2021, and had not recovered from chills described as she was jumping the chills were so strong, and they were better during the daytime, body aches, joint pain, and felt weak. This report was non-serious.
FEELING ABNORMAL FOR A WHILE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced feeling abnormal for a while. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling abnormal for a while. This report was non-serious.
Patient got shingles, and continues to get shingles 10 years later; This spontaneous report was received from a male patient concerning to himself. The patient's medical history, concurrent conditions and concomitant therapies were not provided.   On an unspecified date in 2011 (reported as 10 years ago), the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, frequency, route, lot#, expiration date were not provided) for prophylaxis.   On an unspecified date in 2011, the patient experienced shingles and continued to have shingles 10 years later. Unspecified treatment was prescribed for the event and the patient sought medical attention. At the time of the report, the outcome of the event was not recovered.  The causal relationship between the event and zoster vaccine live (ZOSTAVAX) was not provided.
Moderna COVID-19 Vaccine EUA.  Muscle aches, joint aches.  Personal physician contact on 2nd day of symptoms and recommended 2 Bufferin tablets every 6 hours.  Symptoms began diminishing after first ingestion of Bufferin.
Coughing with production of solid green phlegm from lungs. Coughing began Friday, increasing over past few days. Moderate pain from injection site persists. Unable to raise arm without significant discomfort.
Patient experiencing low grade fever and flu like symptoms - tired, low, energy, aches and pains.
5 - 6 days post vax, pt would come home from school very tired and take naps after school.  This lasted for about 3 weeks. The pt is afebrile and is fine now.
Local redness, non-raised at injection site 2cm diameter. Mother called Benadryl PO given per protocol and parent permission no further s/s.
p/vax pt devel severe red rashes around entire upper arm of inj site area;pt devel significant dependent edema extending from the pt elbow to the wrist;tx w/DPH & recovered w/in 48hr;
Swelling of injection site 5 mins post injection. Itching of injection site and surrounding area 10 mins post injection
I thought I was having allergies due to the season change around here. I was coughing up phlegm, sneezing, postnasal drip, I did have a small temperature. I had been at an even where people got sick. I did take a test for COVID-19 and it was negative. I was so fatigued that I stayed in bed for three days. I had a virtual appointment with my PCP, and they said it was a bad upper respiratory infection. They said it was bacterial and I was put on a Z-PAK. It took about three weeks to really recover.
I started noticed in January, high blood pressure but thought it was allergy problems. The allergist found nothing. My blood pressure has been running 175/150 at one doctor visit. Recently it was 175/111. My blood pressure has been up for 3 months and has not come down. We have doubled up on my blood pressure medication. I diet and exercise and the only thing different is getting the booster shot. I went to the emergency room and was given medication to ease my blood pressure but it came back up again the next day. Chlorthalidone 25mg is what I have been given to bring my blood pressure back down.
6 hours after 2nd dose of vaccine I could feel my body starting to react.  Aches and pains increased as the time went on.  I went to bed and around 12 hours after the injection I got a headache that was unbearable.  It felt like someone was hitting my head with an ax. The pain was  excruciating.  I went through the night with the pain feeling like my head would explode.  In the morning I was totally exhausted and my body hurt all over.  I took Tylenol and went back to bed.  Put warm cloths on my head and face.  My sinus hurt, my teeth hurt. my throat hurt. my eyes hurt.  Awful!!! Spent the entire day in bed.  I continued taking Tylenol every 6 hours.  It did help a little.  By Friday I was seeming to feel a little better.  Still have mild headache and body aches and stomach upsets; but better than the first 24-36 hours.  Hoping to continue to improve each day.  Never expected any side effects as severe.  Most people said sore arm and feeling tired.  I do hope the worse is over.
Patient in immunization area felt dizzy and weak. The patient was taken to the Treatment area in a wheelchair. The patient was moved to the stretcher where the lower extremities were raised and she was covered because she is cold to the touch. The patient is evaluated and consulted by Doctor. She leaves her under observation for 30 minutes. At 4:03 Doctor was consulted again, and she authorized the discharge of the patient wish states she felt good.
LEFT SHOULDER SWELLING AND PAIN AROUND INJECTION SITE FOR 1 WEEK.
Nausea, vomiting, diarrhea, urticaria identical to but more severe than her usual nut allergy sx. Nut allergy is not listed as a contraindication.
New onset joint pain w/neuropathy. Possible permanent unknown outcome. Referring to neurologist.
Nausea, warmth after vaccine. Initial BP, 89/51. Final BP 111/47; blood glucose 85. Drank water.
On the 9th day after receiving the Moderna vaccine, I developed a  red rash, itching and aching at the injection site. The reaction resolved itself within 24hrs
Pt had mild SOB , lightheaded and felt warm rush apx 5-10 minutes after vaccination, Tx with IM benadryl and given apple juice and remained stable, improved, no wheezing, seen at medical triage area on site
Fever and chills Oct 10-11, Tylenol q 4-6 hours. Injection site down right arm and right breast painful to touch Oct 11-13. Right armpit painful when touched and with movement Oct 10-14.
Fever; Initial information was received on 11-Oct-2020 regarding an unsolicited non-valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (unspecified age and gender) who had fever (pyrexia), while received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious fever (pyrexia) next day following the administration of INFLUENZA VACCINE.   No laboratory data was provided.  The patient was treated with IBUPROFEN for pyrexia.  At the time of report, the outcome of event was unknown.  There will be no information available on the lot number for this case.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021; Covid-19 vaccine that were given beyond the 30 day use by date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) in a 28-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day as Moderna COVID-19 Vaccine to the patient. It was unknown if patient received other vaccines within one month prior to any dose of Moderna COVID-19 Vaccine.     On 12-Feb-2022 at 1:28 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 12-Feb-2022 at 1:28 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug information was provided. The 30 days Expiry date vaccine went into 2 to 8 °C thaw state on or about to 20-Dec-2021, this vaccine administered until its Mfg date of 04-Apr-2022  No treatment drug information was received.   This case was linked to MOD-2022-542869.
Case number PHEH20143US024518 is an initial spontaneous report received from a medical assistant on 20 NOV 2013 and a follow up information received from a medical assistant on 02 JAN 2014. This report refers to a 17-year-old female patient. On 14 NOV 2013, she received only Men A lyophilized conjugate component of MENVEO (batch number: M12121) reconstituted with sterile water instead of Men CYW-135 liquid component intramuscularly in the left arm at a dose of 0.5 ml. No adverse reaction was reported following this administration error as of 14 NOV 2013.  Follow up information received from a medical assistant on 02 JAN 2014: Patient demographics (height and weight) and vaccination details (site and time) were updated.
felt and looked like an itchy sunburn/Patient's rib cage on up, both in back and front were itchy and slightly red; felt and looked like an itchy sunburn; Patient's rib cage on up, both in back and front were slightly red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (felt and looked like an itchy sunburn/Patient's rib cage on up, both in back and front were itchy and slightly red), SUNBURN (felt and looked like an itchy sunburn) and ERYTHEMA (Patient's rib cage on up, both in back and front were slightly red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PRURITUS (felt and looked like an itchy sunburn/Patient's rib cage on up, both in back and front were itchy and slightly red), SUNBURN (felt and looked like an itchy sunburn) and ERYTHEMA (Patient's rib cage on up, both in back and front were slightly red). At the time of the report, PRURITUS (felt and looked like an itchy sunburn/Patient's rib cage on up, both in back and front were itchy and slightly red), SUNBURN (felt and looked like an itchy sunburn) and ERYTHEMA (Patient's rib cage on up, both in back and front were slightly red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included Benadryl. No concomitant medications were provided by reporter.
Pt was given Tdap twice during her pregnancy. Once on June 10th, 2021 and a second time on June 30th, 2021. Pt did not have an adverse signs or symptoms following this event.
Information has been received regarding a case in litigation from a lawyer and refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies were not reported. On or about 25-JUL-2015, the patient was vaccinated with ZOSTAVAX, (strength, route, anatomical location, dose, frequency, dose number, lot number and expiration date were not reported), for the permanent prevention and protection against shingles and zoster-related conditions/injuries (prophylaxis). No other suspect or concomitant therapies were reported. On an unknown date in 2015, the patient was diagnosed with shingles (herpes zoster), and on an unknown date the patient was diagnosed with other zoster-related injuries after and despite being inoculated with the ZOSTAVAX (vaccination failure), and suffered serious physical, emotional, and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life (Quality of life decreased); increased risk of premature death, aggravation of pre-existing conditions and activations of latent conditions (condition aggravated), lost wages, loss of earning capacity and other losses and damages. On an unknown date in August 2015, the patient was treated for shingles. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter determined adverse events as medically significant, disabling and life-threatening events.
Day 7 woke up with  swelling at injection site, over the next few hours the area grew to about the size of a baseball, and was red and hot to touch. Area was swollen and hard and very itchy, remained this way for the day into the night growing slightly larger, the following day the swelling went down, but the area circumference grew by half an inch but the center was now a darker color almost yellow brownish but not tender to the touch. the area that had grown was still a bit raised and red, warm to touch.  And that is where I am still at today Monday.
Information has been received from a physician concerning a female patient over 65 years old, who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (Lot # was not provided). The patient experienced a herpes zoster rash. The patient developed the rash on her lumbar or her neck. Additional information is expected.
mesh like vision; Blue chicken wires vision; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VISION BLURRED (mesh like vision) and CYANOPSIA (Blue chicken wires vision) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Macular degeneration. Concomitant products included OMEPRAZOLE, VITAMINS NOS and CYANOCOBALAMIN (COBALAMIN) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced VISION BLURRED (mesh like vision) and CYANOPSIA (Blue chicken wires vision). At the time of the report, VISION BLURRED (mesh like vision) outcome was unknown and CYANOPSIA (Blue chicken wires vision) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Magnetic resonance imaging: normal (normal) normal. In January 2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Eye drops for macular degeneration and dry eyes. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-074784 (E2B Linked Report).; Sender's Comments:  MOD-2021-074784:
Patient was given the Pfizer vaccine shot that was past stability in the fridge for more than 10 hours on 07/17/2021.
This spontaneous report as received from a healthcare worker refers to a 64 year old male patient. The patient's medical history was not reported. On 25-JUN-2014 (reported as today) the patient was vaccinated with PROQUAD (Dose/Frequency: 0.5 milliliter (ml) subcutaneous in the left arm. Concomitant medications were not reported. On 25-JUL-2014, the patient was vaccinated with PROQUAD and VARIVAX. The patient was supposed to get vaccinated with MMR II and VARIVAX. No adverse effects reported. The outcome of wrong vaccine administered was unknown. Additional information is not expected.
This spontaneous report as received from a doctor of pharmacy refers to multiple patients of unknown age. The patients were vaccinated with a dose of ZOSTAVAX, (lot #, dose and route not reported). No other co-suspects were reported. No concomitant medications were reported. The doctor of pharmacy reported that one of the facilities that he was in charge of was recording the temperature of the storage unit of ZOSTAVAX as -5F. He reports that they recently discovered that the actual temperature of the storage unit is -5C. At the time of the call, he does not know which lot numbers were involved, how long the storage unit was set at -5C, nor how many patients have received the improperly stored doses of ZOSTAVAX. He did not know if any patients had experienced any adverse effects. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
She complained of numbness and feeling dizzy and nauseous after 5 minutes receiving the vaccine. She wasn't getting better after 20 minutes called an ambulance and medics checked on her vital signs and everything  normal except that she was hyperventilating. She refused to go to a hospital and she stayed for another hour and her boyfriend came to pick her up after feeling better.